Investigación

 

Furanoeremophilane Derivatives from Psacalium beamanii

 

Ana L. Pérez-Castorena,¹* Amira Arciniegas,¹ José Luis Villaseñor,² Alfonso Romo de Vivar¹

 

¹ Instituto de Química.

²Instituto de Biología, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán 04510, D.F., México. Tel.: (5255) 56-224412. Fax: (5255) 56-162217. E-mail: alperezc@servidor.unam.mx

 

Recibido el 24 de noviembre del 2003.
Aceptado el 26 de febrero del 2004.

 

Abstract

The phytochemical study of Psacalium beamanii afforded the phenylethanoid 1, three sterols, the furanoeremophilane derivatives 2-10, and maturone acetate (12), which was isolated as a natural product for the first time. Its structure was established by means of spectroscopic data and confirmed by chemical correlation. The optical rotation of decompostin (4) was corrected and its identity was corroborated by the X ray analysis of its 2S-bromo derivative (11).

Keywords: Psacalium beamanii, Asteraceae, Senecioneae, Tussilagininae, furanoeremophilane derivatives.

 

Resumen

El estudio fitoquímico de Psacalium beamanii permitió el aislamiento del feniletanoide 1, tres esteroles, los furanoeremofilanos 2-10, y el acetato de maturona (12), el cual fue aislado por primera vez como producto natural. Su estructura se estableció por medio de sus datos espectroscópicos y se confirmó por correlación química. La rotación óptica de la decompostina (4) se corrigió y su identidad se corroboró por el análisis de rayos X de su derivado 2S-bromo (11).

Palabras clave: Psacalium beamanii, Asteraceae, Senecioneae, Tussilagininae, derivados de furanoeremofilano.

 

Dedicated to the memory of Dr. Raymundo Cruz Almanza

 

Introduction

The genus Psacalium (Asteraceae, Senecioneae, Tussilagininae) comprises about 47 species distributed from southwestern United States to Guatemala [1]. Previous chemical studies have shown that eremophilanes are the main secondary metabolites elaborated by species of this genus [2-5]. P. decompositum, P. palmeri, P. peltatum, P. sinuatum, P. radulifolium and Acourtia thurberi are grouped by the Tarahumara ethnia of northern Mexico, in the so called Matarique complex, and used for the treatment of rheumatism and diabetes, as well as renal, hepatic and gastrointestinal ailments [6]. Ethnomedical information has motivated several research projects such as the evaluation of the antihyperglycemic activity of P. decompositum and P. peltatum extracts [4,7], and the antimicrobial activity of P. radulifolium extracts [5]. Thus, in order to continue with the phytochemical research of Mexican plants of the Senecioneae tribe [8], we studied Psacalium beamanii H. Rob. In the present study, we report the isolation of a phenylethanoid (1), three sterols, and nine furanoeremophilane derivatives (2-10). Additionally, the characterization of maturone acetate (12), isolated as a natural product, for the first time, is also described.

 

Results and discussion

The phytochemical study of Psacalium beamanii afforded the known compounds β-sitosterol, stigmasterol, β-sitosterol glucoside [9], the phenylethanoid icariside D₂ (1) [10], the furanoeremophilane derivatives maturinone (2) [11], maturone (3) [2], decompostin (4) [12], maturinin (5) [2,13], maturin acetate (6) [2,13], cacalonol (7/8) [14] and peroxycacalonol (9/10) [14]. The steroidal compounds were identified by comparison with authentic samples, and compounds 1-10 by comparison of their physical and spectroscopic features with those described in literature.

Cacalonol and peroxycacalonol were optically inactive, suggesting the presence of 1:1 mixtures of the corresponding enantiomers (7/8 and 9/10 respectively). Compound 4, identified as decompostin by means of its mp and spectral data, showed a specific rotation ([α]_D²⁹-68°) with opposite sign to that reported in literature [12]. Its 2α-bromo derivative 11 exhibited an [α]_D²⁹-426°, which also differed from that reported for the same compound ([α]_D-41.4°) [12]. In order to clarify this ambiguity, an x-ray crystallographic analysis of the 2S-bromo derivative (Fig 1) was performed, thus confirming the structure and absolute configuration of decompostin (4) and showing that the reported specific rotations of 4 and 11 were mistaken.

In addition to the above mentioned, modified furanoeremophilane 12 was isolated as a crystalline yellow solid, mp 150-1º. Its molecular formula C₁₆H₁₂O₅ deduced from HREIMS (m/z 284.068, [M]⁺) as well as its UV (λ_max 246, 293 and 350 nm) and IR (ν_max 1670, 1585and 1543 cm^-1) spectra suggested an aromatic structure with a quinoid system. This was corroborated by the two singlet signals at δ 183.54 and 173.62 (C-6 and C-9 respectively) observed in the ¹³C NMR spectrum. The presence of an acetate group was deduced by its characteristic signals (δ_H 2.14, δ_C 20.85 and δ_C 170.56) observed in the ¹H and ¹³C NMR spectra. The remaining signals in both spectra showed a structural relationship with maturone (3). The main difference observed in ¹H NMR spectrum of 12 was the downfield shift of the C-13 methylene signal (δ 5.38), in agreement with the presence of an acetate group bonded to this carbon atom. The structure and identity of 12 were confirmed when maturin acetate (6) was transformed into 12 by Jones oxidation. Maturone acetate was reported as an acetylation product of maturone [2]. Nevertheless, this is the first time that 12 is isolated as a natural product and fully characterized by ¹H, ¹³C, COSY, HETCOR, and COLOC NMR spectral data.

 

Experimental

General Experimental Procedures

Melting points were determined on a Fisher Jones melting point apparatus and are uncorrected. Optical rotations were determined on a JASCO DIP-360 digital polarimeter. IR spectra were recorded on a Nicolet Magna-IR 750 spectrometer. EIMS data were determined on a JEOL JMS-AX505HA mass spectrometer at 70 eV. ¹H NMR and ¹³C NMR data were obtained on a Varian Unity 300 instrument. Chemical shifts were referred to TMS (δ 0). Standard Varian programs were used for COSY spectra at 300 MHz. HETCOR experiments were obtained for ¹J_CH = 140 Hz at 75 MHz. COLOC experiments were obtained for ⁿJ_CH = 9 Hz at 75 MHz. Vacuum column chromatographies (VCCs) were performed using Sil G 60 E. Merck, 70-230 mesh.

Plant Material

Psacalium beamanii H. Rob. was collected in Ixtlán, Oaxaca, México, June 1997. A voucher specimen (MEXU 775149) was deposited at the Herbario Nacional, Instituto de Biología, UNAM, México.

Extraction and Isolation

Dried and ground roots (129 g) were extracted successively with hexane and MeOH at room temperature. Hexane extract (4.47 g) was analyzed by VCC eluting with an hexane/EtOAc gradient system. Fractions eluted with hexane were combined and purified by means of VCC (hexane/EtOAc 99:1) to yield maturinone (2, 11.1 mg) [11], mp 169-72°. Fractions eluted with hexane/EtOAc 90:10 afforded maturone acetate (12, 44 mg) [2], mp 150-1°. The mother liquors of the last compound and fractions eluted with hexane/EtOAc 85:15 were combined and submitted to VCC (hexane/EtOAc 95:5) to yield decompostin (4, 49.4 mg) [12], mp 195-6°, [α]_D²⁹ -68° (c 0.456, CHCl₃), and 12 (37.9 mg). Decompostin (4, 19 mg) was transformed into 2S-bromodecompostin (11, 6 mg) as already described [12], mp 188-192° dec, [α]_D²⁹ -426° (c 0.2, CHCl₃). MeOH extract (28 g) was purified by VCC eluting with an hexane/Me₂CO gradient system. Fractions eluted with hexane were analyzed by VCC (hexane/EtOAc 99:1) affording maturinin (5, 18.1 mg) [2, 13], mp 94-6°, 2 (4.4 mg) and a mixture of β-sitosterol/stigmasterol (25 mg), mp 134-6º. Fractions eluted with hexane/Me₂CO 90:10 were submitted to VCC (hexane/EtOAc 95:5) to yield 4 (123.6 mg) and maturin acetate (6, 125.5 mg) [2, 13], mp 84-6°. Fractions eluted with hexane/Me₂CO 80:20 were purified by VCC (hexane/EtOAc 85:15) affording cacalonol (7/8, 11.4 mg) [14], mp 205-7°, [α]_D²⁹ 0º (c 0.26, CHCl₃) and maturone (3, 3 mg) [2], mp 164-70°. Dried and ground aerial parts (476.2 g) were extracted with hexane and MeOH. Hexane extract (12.7 g) was submitted to VCC eluting with an hexane/Me₂CO gradient system. Fractions eluted with hexane/Me₂CO 95:5 afforded a mixture of β-sitosterol/stigmasterol (25 mg). Fractions eluted with hexane/Me₂CO 90:10 yielded 7/8 (33.4 mg) and peroxycacalonol (9/10, 34.7 mg) [14], mp 204-6° dec., [α]_D²⁹ 0º (c 0.185, CHCl₃). The MeOH extract (100 g) was analyzed by VCC eluting with an hexane/Me₂CO gradient system. Fractions eluted with hexane/Me₂CO 95:5 were purified by VCC (hexane/EtOAc 90:10) yielding a mixture of β-sitosterol/stigmasterol (28 mg), and 12 (10.6 mg). Fractions eluted with hexane/Me₂CO 90:10 and 85:15 were combined and purified by VCC (hexane/EtOAc 85:15) affording 12 (2.1 mg), 7/8 (31.6 mg), and 3 (17.5 mg). Fractions eluted with hexane/Me₂CO 50:50 and 40:50 were combined and analyzed by VCC (CHCl₃/MeOH 95:5) to give β-sitosterol glucopyranoside (75.6 mg) [9], mp 285-90º. Fractions eluted with hexane/Me₂CO 30:70 were treated with charcoal/MeOH and submitted to VCC (CHCl₃/MeOH 80:20) to yield icariside D₂ (1, 148.3 mg) [10], mp 153-5°.

Maturone acetate (12). Yellow crystals from hexane/EtOAc, mp 150-1° [2]. UV (MeOH): λ_max (log ε) 204 (4.25), 246 (4.45), 293 (3.83), 350 nm (3.71). IR (CHCl₃):ν_max 1744, 1670, 1585, 1543 cm^-1. EIMS m/z (rel. int.) 284 [M]⁺ (10), 242 [M-42]⁺ (15), 224 [M-HOAc]⁺ (100), 196 [224-28]⁺ (5), 168 [196-28]⁺ (16), 139 [168-29]⁺ (20), 43 [C₂H₃O]⁺ (63). HREIMS m/z [M]⁺ 284.0681 (calcd for C₁₆H₁₂O₅ 284.0685). ¹H-NMR (300 MHz, CDCl₃): δ 8.17 (1H, br d, J = 6.6 Hz, H-1), 7.61 (1H, t, J = 7.5 Hz, H-2), 7.54 (1H, br d, J = 7.2 Hz, H-3), 7.76 (1H, s, H-12), 5.38 (2H, s, H-13), 2.81 (3H, s, H-15), 2.14 (3H, s, Ac). ¹³C-NMR (75 MHz, CDCl₃): δ 125.99 (C-1), 132.94 (C-2), 138.49 (C-3), 142.29 (C-4), 130.55 (C-5), 183.54 (C-6), 128.70 (C-7), 152.17 (C-8), 173.62 (C-9), 134.05 (C-10), 121.61 (C-11), 147.10 (C-12), 56.47 (C-13), 23.12 (C-15), 170.56 (C=O, Ac), 20.85 (CH₃, Ac).

Oxidation of maturin acetate (6). A solution of 6 (27.8 mg) in Me₂CO (2 ml) at 3° was oxidized with Jones reactive in the usual manner. The residue purified by VCC (hexane/EtOAc 80:20) gave maturone acetate (12, 16.4 mg), mp 149-51°.

X-ray crystallographic data of 11. Colorless crystal obtained from CHCl₃/Et₂O; crystal size 0.206 × 0.144 × 0.052 mm; crystal data: C₁₇H₁₉BrO₄, mol. wt = 367.23, monoclinic, space group P2₁, a = 7.242 (1) Å, b = 8.321 (1) Å, c = 14.131 (1) Å, β = 103.535 (2)°, V = 827.9 (2) ų, Z = 2, Dc = 1.473 Mg/m³, F (000) = 376, T = 293 (2) K, µ = 2.497 mm^-1, λ (Mo Kα) = 0.71073 Å, 6805 measured intensities (2.86 < θ < 25.03°), -8 ≤ h ≤ 8, -9 ≤ k ≤ 9, -16 ≤ l ≤16, collected Bruker Smart Apex CCD diffractometer. Refinement by the full matrix-least squares on F² method was performed using 2907 reflections (> 2σ (I)) with 203 parameters. The largest difference peak was 0.497. The final R-factor was 4.04 % and wR² was 5.6 %. Flack's parameter = -0.05 (1). Crystallographic data have been deposited at the Cambridge Crystallographic Data Center (CCDC 232110), 12 Union Road, Cambridge, CB2 1EZ, UK.

 

Acknowledgement

We are indebted to Rubén Toscano, Rubén Gaviño, María Isabel Chávez, Héctor Ríos, Angeles Peña, Rocío Patiño, Luis Velasco, Javier Pérez, and Gabriela Salcedo for technical assistance.

 

References

1. Barkley, T. M.; Clark, B. L.; Funston, A. M. Proceedings of the International Compositae Conference, Kew 1994. Hind, D. J. N., Ed., Royal Botanical Gardens: Kew, 1996; Vol. 1. p. 613-620.         [ Links ]

2. Correa, J.; Romo, J. Tetrahedron 1966, 22, 685-691.         [ Links ]

3. Joseph-Nathan, P.; Negrete, M. C.; González, M. P. Phytochemistry 1970, 9, 1623-1628.         [ Links ]

4. Inman, W. D.; Luo, J.; Joland, S. D.; King, S. T.; Cooper, R. J. Nat. Prod. 1999, 62, 1088-1092.         [ Links ]

5. Garduño-Ramírez, M. L.; Trejo, A.; Navarro, V.; Bye, R.; Linares, E.; Delgado, G. J. Nat. Prod. 2001, 64, 432-435.         [ Links ]

6. Bye, R.; Linares, E.; Estrada, E., in: Phytochemistry of Medicinal Plants, Arnason, J. T.; Mata, R.; Romeo, J. T. Ed., Plenum Press, New York, 1995, 65.         [ Links ]

7. Alarcón-Aguilar, F. J.; Jiménez-Estrada, M.; Reyes-Chilpa, R.; González-Paredes, B.; Contreras-Weber, C. C.; Román-Ramos, R. J. Ethnopharmac. 2000, 69, 207-215.         [ Links ]

8. Pérez-Castorena, A. L.; Arciniegas, A.; Ramírez A. M. T.; Villaseñor, J. L.; Romo de Vivar, A. Planta Med. 2002, 66, 645-647.         [ Links ]

9. Voutquenne, L.; Lavaud, C.; Massiot, G.; Sevenet, T., Hadi, H. A. Phytochemistry 1999, 50, 63-69.         [ Links ]

10. Miyase, T.; Ueno, A.; Takizawa, N.; Kobayashi, H., Oguchi, H. Phytochemistry 1989, 28, 3483-3485.         [ Links ]

11. Brown, P. M.; Thomson, R. H. J. Chem. Soc. C 1969, 1184-1186.         [ Links ]

12. Rodríguez-Hahn, L.; Guzmán, A.; Romo, J. Tetrahedron 1968, 24, 477-483.         [ Links ]

13. Bohlmann, F.; Zdero, C.; Grenz, M. Chem. Ber. 1977, 110, 474-486.         [ Links ]

14. Naya, K.; Miyoshi, Y.; Mori, H.; Takai, K.; Nakanishi, M. Chem. Lett. 1976, 73-76.         [ Links ]

 

Nota

Contribution 2465 of the Instituto de Química, UNAM.